Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1980 1
1981 1
1985 4
1986 1
1987 4
1988 5
1989 11
1990 4
1991 2
1992 4
1993 6
1994 5
1995 14
1996 6
1997 5
1998 2
1999 7
2000 16
2001 10
2002 14
2003 15
2004 25
2005 19
2006 12
2007 9
2008 18
2009 19
2010 15
2011 13
2012 9
2013 8
2014 13
2015 10
2016 6
2017 13
2018 17
2019 17
2020 16
2021 12
2022 8
2023 11
2024 5
2025 7
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Results by year

Filters applied: . Clear all
Page 1
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
Bohula EA, Marston NA, Bhatia AK, De Ferrari GM, Leiter LA, Nicolau JC, Park JG, Kuder JF, Murphy SA, Walsh E, Wang H, Blaha V, Budaj A, Cornel JH, Goudev A, Kiss RG, Lorenzatti AJ, Parkhomenko A, Cyrille M, Paiva da Silva Lima G, Ohman EM, Giugliano RP, Sabatine MS; VESALIUS-CV Investigators. Bohula EA, et al. N Engl J Med. 2026 Jan 8;394(2):117-127. doi: 10.1056/NEJMoa2514428. Epub 2025 Nov 8. N Engl J Med. 2026. PMID: 41211925 Clinical Trial.
BACKGROUND: The proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, stroke, or symptomatic peripheral artery disease. The effect of e …
BACKGROUND: The proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular …
Fish Consumption and Coronary Heart Disease: A Meta-Analysis.
Zhang B, Xiong K, Cai J, Ma A. Zhang B, et al. Nutrients. 2020 Jul 29;12(8):2278. doi: 10.3390/nu12082278. Nutrients. 2020. PMID: 32751304 Free PMC article.
Epidemiological studies on the impact of fish consumption on coronary heart disease (CHD) incidence have shown inconsistent results. ...This meta-analysis indicates that fish consumption is associated with a lower CHD incidence and mortality …
Epidemiological studies on the impact of fish consumption on coronary heart disease (CHD) incidence have shown i …
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators. Sabatine MS, et al. N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17. N Engl J Med. 2017. PMID: 28304224 Free article. Clinical Trial.
METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of 70 mg per deciliter (1.8 mmol per liter) or higher who were receiving statin therapy. ...These fin …
METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular …
Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies.
Marckmann P, Grønbaek M. Marckmann P, et al. Eur J Clin Nutr. 1999 Aug;53(8):585-90. doi: 10.1038/sj.ejcn.1600832. Eur J Clin Nutr. 1999. PMID: 10477243
Results of four studies of intermediate quality support that fish consumption is inversely associated with coronary heart disease mortality in high-risk populations only. ...However, fish consumption at 40-60 g daily is associated with ma …
Results of four studies of intermediate quality support that fish consumption is inversely associated with coronary heart …
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Siscovick DS, et al. Circulation. 2017 Apr 11;135(15):e867-e884. doi: 10.1161/CIR.0000000000000482. Epub 2017 Mar 13. Circulation. 2017. PMID: 28289069 Free PMC article. Review.
Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty acids, commonly called fish oils) on the occurrence of clinical cardiovascular diseases. Although t …
Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation with eicosapentaenoic acid plus docosahexaenoic ac …
Vitamin D and cardiovascular health.
de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H. de la Guía-Galipienso F, et al. Clin Nutr. 2021 May;40(5):2946-2957. doi: 10.1016/j.clnu.2020.12.025. Epub 2020 Dec 29. Clin Nutr. 2021. PMID: 33397599 Free PMC article. Review.

In lesser amounts, the vitamin can be obtained from the diet, mostly from fatty fish, fish liver oil and mushrooms. Individuals with vitamin D deficiency, defined as a serum level of 25 hydroxyvitamin D < 20 ng/dl, should be supplemented. ...Its deficiency has be

…
In lesser amounts, the vitamin can be obtained from the diet, mostly from fatty fish, fish liver oil and mushrooms. Individual …
Associations of Processed Meat, Unprocessed Red Meat, Poultry, or Fish Intake With Incident Cardiovascular Disease and All-Cause Mortality.
Zhong VW, Van Horn L, Greenland P, Carnethon MR, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB. Zhong VW, et al. JAMA Intern Med. 2020 Apr 1;180(4):503-512. doi: 10.1001/jamainternmed.2019.6969. JAMA Intern Med. 2020. PMID: 32011623 Free PMC article.
IMPORTANCE: Although the associations between processed meat intake and cardiovascular disease (CVD) and all-cause mortality have been established, the associations of unprocessed red meat, poultry, or fish consumption with CVD and all-cause mortality …
IMPORTANCE: Although the associations between processed meat intake and cardiovascular disease (CVD) and all-cause mortality h …
Omega-3 fatty acids and cardiovascular disease.
Jain AP, Aggarwal KK, Zhang PY. Jain AP, et al. Eur Rev Med Pharmacol Sci. 2015;19(3):441-5. Eur Rev Med Pharmacol Sci. 2015. PMID: 25720716 Free article. Review.
Omega-3 fatty acids have been shown to significantly reduce the risk for sudden death caused by cardiac arrhythmias and all-cause mortality in patients with known coronary heart disease. Omega-3 fatty acids are also used to treat hyperlipidemia and hyp …
Omega-3 fatty acids have been shown to significantly reduce the risk for sudden death caused by cardiac arrhythmias and all-cause mortali …
Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies.
He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. He K, et al. Circulation. 2004 Jun 8;109(22):2705-11. doi: 10.1161/01.CIR.0000132503.19410.6B. Circulation. 2004. PMID: 15184295
BACKGROUND: Results from observational studies on fish consumption and coronary heart disease (CHD) mortality are inconsistent. METHODS AND RESULTS: A meta-analysis of cohort studies was conducted to examine the association between fish i …
BACKGROUND: Results from observational studies on fish consumption and coronary heart disease (CHD) mortality …
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2020 Feb 29;3(3):CD003177. doi: 10.1002/14651858.CD003177.pub5. Cochrane Database Syst Rev. 2020. PMID: 32114706 Free PMC article.
Increasing LCn3 may slightly reduce coronary heart disease mortality (number needed to treat for an additional beneficial outcome (NNTB) 334, RR 0.90, 95% CI 0.81 to 1.00; 127,378 participants; 3598 coronary heart disease deaths in …
Increasing LCn3 may slightly reduce coronary heart disease mortality (number needed to treat for an additional b …
394 results